Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
51
IONS Quote, Financials, Valuation and Earnings
Last price:
$80.65
Seasonality move
:
6.22%
Day range:
$80.33 - $81.02
52-week range:
$23.95 - $83.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.73x
P/B ratio:
21.14x
Volume:
480.2K
Avg. volume:
2.7M
1-year change:
120.78%
Market cap:
$13.1B
Revenue:
$705.1M
EPS (TTM):
-$1.71
Earnings Data
Next earnings date for IONS
Feb 18
2026
Most recent earnings per share
-$0.81
Beat by $0.25
(Oct 29/2025)
Consensus Estimate
-$1.05
(Oct 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
IONS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/18/2026 | Q4 | $153.1M | -- | -- | -$1.19 | -- |
| 10/29/2025 | Q3 | $130.5M | $156.7M | -$0.81 | -$1.05 | $0.25 |
| 07/30/2025 | Q2 | $299M | $452M | $0.68 | $0.16 | $0.51 |
| 04/30/2025 | Q1 | $122.5M | $131.6M | -$0.93 | -$1.03 | $0.11 |
| 02/19/2025 | Q4 | $139.2M | $227M | -$0.66 | -$0.84 | $0.19 |
| 11/06/2024 | Q3 | $129.9M | $133.8M | -$0.95 | -$0.98 | $0.04 |
| 08/01/2024 | Q2 | $149.8M | $225.3M | -$0.45 | -$0.76 | $0.31 |
| 05/07/2024 | Q1 | $136.4M | $119.5M | -$0.98 | -$0.83 | -$0.15 |
| 02/21/2024 | Q4 | $170.9M | $325M | -$0.06 | -$0.75 | $0.69 |
| 11/02/2023 | Q3 | $136.4M | $144.2M | -$1.03 | -$0.89 | -$0.14 |
| 08/09/2023 | Q2 | -- | $188.4M | -$0.60 | -- | -- |
| 05/03/2023 | Q1 | -- | $130.5M | -$0.87 | -- | -- |
| 02/22/2023 | Q4 | -- | $152M | -$0.37 | -- | -- |
| 11/09/2022 | Q3 | -- | $159.8M | -$0.33 | -- | -- |
| 08/09/2022 | Q2 | -- | $133.8M | -$0.74 | -- | -- |
| 05/04/2022 | Q1 | -- | $141.9M | -$0.46 | -- | -- |
| 02/24/2022 | Q4 | -- | $440M | $1.40 | -- | -- |
| 11/03/2021 | Q3 | -- | $133.1M | -$0.58 | -- | -- |
| 08/04/2021 | Q2 | -- | $125.8M | -$0.57 | -- | -- |
| 05/05/2021 | Q1 | -- | $111.6M | -$0.64 | -- | -- |
| 02/24/2021 | Q4 | -- | $290M | -$2.54 | -- | -- |
| 11/04/2020 | Q3 | -- | $160.1M | -$0.18 | -- | -- |
| 08/05/2020 | Q2 | -- | $145.5M | -$0.18 | -- | -- |
| 05/06/2020 | Q1 | -- | $133.4M | -$0.28 | -- | -- |
| 02/26/2020 | Q4 | -- | $493.7M | $1.20 | -- | -- |
| 11/06/2019 | Q3 | -- | $167.9M | $0.18 | -- | -- |
| 08/07/2019 | Q2 | -- | $163.8M | -$0.01 | -- | -- |
| 05/09/2019 | Q1 | -- | $297.2M | $0.62 | -- | -- |
| 02/27/2019 | Q4 | -- | $192.1M | $2.21 | -- | -- |
| 11/06/2018 | Q3 | -- | $145.4M | -$0.03 | -- | -- |
| 08/07/2018 | Q2 | -- | $117.7M | -$0.31 | -- | -- |
| 05/04/2018 | Q1 | -- | $144.4M | -$0.01 | -- | -- |
| 02/27/2018 | Q4 | -- | $167.8M | $0.02 | -- | -- |
| 11/07/2017 | Q3 | -- | $118.3M | -$0.02 | -- | -- |
| 08/08/2017 | Q2 | -- | $112.3M | -$0.02 | -- | -- |
| 05/09/2017 | Q1 | -- | $115.8M | $0.07 | -- | -- |
| 02/28/2017 | Q4 | -- | $160.3M | $0.21 | -- | -- |
| 11/09/2016 | Q3 | -- | $110.9M | $0.06 | -- | -- |
| 08/09/2016 | Q2 | -- | $38.5M | -$0.47 | -- | -- |
| 05/04/2016 | Q1 | -- | $36.9M | -$0.52 | -- | -- |
| 02/25/2016 | Q4 | -- | $51.6M | -$0.59 | -- | -- |
Ionis Pharmaceuticals, Inc. Earnings Questions
-
How Much did Ionis Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Ionis Pharmaceuticals, Inc. reported $156.7M worth of top line sales in its most recent quarter.
-
Did Ionis Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Ionis Pharmaceuticals, Inc. announced earnings per share of -$0.81 which represents a beat of analyst forecast a -$1.05 per share.
-
Is Ionis Pharmaceuticals, Inc. Profitable?
Ionis Pharmaceuticals, Inc. reported $151.5M that represents $0.95 per share over the last quarter.
-
What is the Analyst Consensus for Ionis Pharmaceuticals, Inc. EPS Next Year?
Ionis Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.04 per share to -$2.54 per share next year representing a decrease of -46.94%.
-
When is Ionis Pharmaceuticals, Inc.'s Earnings Date?
Ionis Pharmaceuticals, Inc.'s next earnings date is February 18, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
